BIOMAT Database Logo BIOMAT Database Logo

Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. 1994

K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
First Department of Medicine, Osaka University School of Medicine, Japan.

We assessed hepatitis C virus infection in 156 chronic hepatitis B patients using second-generation hepatitis C virus antibody (anti-HCV). Active virus replication was further investigated in anti-HCV-positive cases by means of polymerase chain reaction assay for the detection of serum hepatitis C virus RNA. Anti-HCV prevalence was higher in patients negative for hepatitis B e antigen (HBeAg) (10/48, 21%) than in HBeAg-positive patients (10/108, 9%) (p < 0.05), and the reactivity (cut-off index) in anti-HCV enzyme-linked immunosorbent assay of the positive cases was significantly higher in HBeAg-negative patients (4.1 +/- 0.1) than in -positive ones (3.6 +/- 0.6) (p < 0.05). The prevalence of hepatitis C virus RNA in anti-HCV-positive cases was also higher in the HBeAg-negative group (9/10, 90%) than in the -positive group (3/10, 30%) (p < 0.01). Viremia was found in association with high reactivity in anti-HCV ELISA (cut-off index > 3.5) in both groups. Nine (90%) of 10 such cases were viremic in the HBeAg-negative group compared with three (43%) of seven in the HBeAg-positive group (p < 0.05). These results suggest that hepatitis C virus replication may be influenced by hepatitis B virus replicative states, indicating possible interference between hepatitis B and C viruses.

UI MeSH Term Description Entries
D008297 Male Males
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Antibody to hepatitis C virus in patients with chronic hepatitis B virus infection.
November 1995, Journal of hepatology,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Chronic Hepatitis B Virus in Patients with Chronic Hepatitis C Virus.
November 2021, Clinics in liver disease,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.
July 1991, Hepatology (Baltimore, Md.),
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Hepatitis C virus replication in 'autoimmune' chronic hepatitis.
November 1991, Journal of hepatology,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C.
January 2006, Hepatology (Baltimore, Md.),
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection.
July 2006, World journal of gastroenterology,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Hepatitis B virus replication in patients with chronic liver diseases.
April 1990, Gastroenterologia Japonica,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Hepatitis B virus activity in patients with anti-hepatitis C virus antibody positivity and hepatitis B antigen positivity.
December 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Patterns of antibodies to hepatitis C virus and hepatitis C virus replication in children with chronic non-A, non-B hepatitis.
December 1994, The Journal of pediatrics,
K Ohkawa, and N Hayashi, and N Yuki, and H Hagiwara, and M Kato, and K Yamamoto, and H Eguchi, and H Fusamoto, and M Masuzawa, and T Kamada
Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
January 2002, Journal of gastroenterology,
Copied contents to your clipboard!